Skip to content
Colorectal Cancer Clinical Trials

Georgia

Colorectal cancer clinical trials in Georgia

55 colorectal cancer studies are recruiting participants at sites in 26 cities across Georgia as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Georgia city with a recruiting study

Atlanta (39), Savannah (10), Newnan (5), Athens (4), Tifton (4), Braselton (3), Columbus (3), Decatur (3), Duluth (3), Gainesville (3), Lawrenceville (3), Augusta (2), Marietta (2), Albany (1), Conyers (1), Dawsonville (1), Fayetteville (1), Fort Eisenhower (1), Hinesville (1), Jesup (1), Johns Creek (1), Locust Grove (1), Macon (1), Snellville (1), Valdosta (1), Warner Robins (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Georgia

Basic details from each study's public record (the 12 most recently updated of 55). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Atlanta
    Registry record
    NCT05863195 · updated
  2. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Recruiting in
    Atlanta
    Registry record
    NCT06983743 · updated
  3. Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Recruiting in
    Savannah
    Registry record
    NCT07775287 · updated
  4. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Atlanta
    Registry record
    NCT07488676 · updated
  5. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Vividion Therapeutics, Inc.
    Recruiting in
    Atlanta
    Registry record
    NCT06004245 · updated
  6. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Recruiting in
    Atlanta
    Registry record
    NCT06270706 · updated
  7. Shield Post-Approval Study Protocol

    • Observational
    • Ages 45 to 81
    • All sexes
    Sponsor
    Guardant Health, Inc.
    Recruiting in
    Conyers · Dawsonville · Fayetteville · and 1 more U.S. location
    Registry record
    NCT06880055 · updated
  8. A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Atlanta
    Registry record
    NCT06997497 · updated
  9. Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Recruiting in
    Savannah
    Registry record
    NCT07750158 · updated
  10. Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Recruiting in
    Augusta · Braselton · Gainesville · and 1 more U.S. location
    Registry record
    NCT07018869 · updated
  11. Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

    • Observational
    • Ages 60 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Recruiting in
    Columbus
    Registry record
    NCT03998202 · updated
  12. A Web-Based Dyadic Intervention for Colorectal Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Emory University
    Recruiting in
    Atlanta
    Registry record
    NCT05663203 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Georgia on ClinicalTrials.gov.

Ask about studies in Georgia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call